Bourdin, Arnaud
for the ISABELA 1 and 2 Investigators
3 papers on CoChatORCID 0000-0002-4645-5209
Most cited papers
- Verified
Ziritaxestat, a Novel Autotaxin Inhibitor, and Lung Function in Idiopathic Pulmonary Fibrosis: The ISABELA 1 and 2 Randomized Clinical Trials
Maher, T. M., Ford, P., Brown, K. K., Costabel, U., Cottin, V., Danoff, S. K., Groenveld, I., Helmer, E., Jenkins, R. G., Milner, J., et al. (2023) · JAMA
Interstitial Lung Diseases and Idiopathic Pulmonary FibrosisChronic Obstructive Pulmonary Disease (COPD) Research
Cited by 148
- Verified
The long-term sequelae of COVID-19: an international consensus on research priorities for patients with pre-existing and new-onset airways disease
Adeloye, D., Elneima, O., Daines, L., Poinasamy, K., Quint, J. K., Walker, S., Brightling, C. E., Siddiqui, S., Hurst, J. R., Chalmers, J. D., et al. (2021) · The Lancet Respiratory Medicine
Long-Term Effects of COVID-19COVID-19 Clinical Research Studies
Cited by 126
- Verified
Expert Consensus on the Tapering of Oral Corticosteroids for the Treatment of Asthma. A Delphi Study
Suehs, C. M., Menzies-Gow, A., Price, D., Bleecker, E. R., Canonica, G. W., Gurnell, M., & Bourdin, A. (2021) · American Journal of Respiratory and Critical Care Medicine
Asthma and respiratory diseasesAdrenal Hormones and Disorders
Cited by 118
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free